Current approach and future perspective for ductal carcinoma in situ of the breast

Ductal carcinoma in situ (DCIS) has a good prognosis with the current treatment approach, with a 10-year breast cancer-specific survival rate of 97–98%. In ductal carcinoma in situ without micrometastasis, surgery and postoperative adjuvant therapy significantly improve local control, however it has...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanbayashi, Chizuko, Iwata, Hiroji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896693/
https://www.ncbi.nlm.nih.gov/pubmed/28486668
http://dx.doi.org/10.1093/jjco/hyx059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896693/
https://www.ncbi.nlm.nih.gov/pubmed/28486668
http://dx.doi.org/10.1093/jjco/hyx059

Ejemplares similares